Viewing StudyNCT00943540



Ignite Creation Date: 2024-05-05 @ 9:42 PM
Last Modification Date: 2024-10-26 @ 10:08 AM
Study NCT ID: NCT00943540
Status: COMPLETED
Last Update Posted: 2020-11-12
First Post: 2009-07-21

Brief Title: Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients
Sponsor: Radboud University Medical Center
Organization: Radboud University Medical Center

Organization Data

Organization: Radboud University Medical Center
Class: OTHER
Study ID: UMCN-AKF 0807
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Radboud University Medical Center
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: DM Burger PhD PharmD
Old Organization: Radboud University Medical Centre Nijmegen

Collaborators